Apyx Medical Corporation
APYX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $32 | $44 | $10 | $31 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $15 | $14 | $18 | $21 |
| Inventory | $8 | $10 | $12 | $7 |
| Other Curr. Assets | $2 | $3 | $3 | $2 |
| Total Curr. Assets | $56 | $70 | $43 | $61 |
| Property Plant & Equip (Net) | $7 | $7 | $8 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $1 | $1 |
| Total NC Assets | $8 | $9 | $9 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $65 | $79 | $52 | $69 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $3 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $2 | $2 |
| Deferred Revenue | $1 | $0 | $1 | $1 |
| Other Curr. Liab. | $7 | $9 | $6 | $7 |
| Total Curr. Liab. | $11 | $13 | $12 | $13 |
| LT Debt | $38 | $38 | $1 | $0 |
| Deferred Rev, NC | $1 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $40 | $40 | $2 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $1 | $0 |
| Total Liabilities | $51 | $52 | $14 | $15 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$78 | -$54 | -$36 | -$13 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $92 | $81 | $73 | $66 |
| Total Equity | $14 | $27 | $38 | $54 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $65 | $79 | $52 | $69 |
| Net Debt | $7 | -$5 | -$9 | -$31 |